Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Bioventus Inc. (BVS) had Revenue of $147.66M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$147.66M
Net Income	$7.46M
Cost of Goods Sold	$45.57M
Gross Profit	$102.09M
Operating Expenses	$129.29M
Operating Income	$18.37M
Non-Operating Income/Expense	$-8.05M
Pre-Tax Income	$10.31M
Normalized Pre-Tax Income	$10.31M
Income after Taxes	$9.27M
Income from Continuous Operations	$9.27M
Consolidated Net Income/Loss	$9.27M
Normalized Income after Taxes	$9.27M
EBIT	$18.37M
EBITDA	$30.42M
Weighted-Average Shares Outstanding (Basic)	66.50M
Weighted-Average Shares Outstanding (Diluted)	68.54M
Earnings per Share (EPS) (Basic)	$0.11
Earnings per Share (EPS) (Diluted)	$0.11
Balance Sheet Financials
Current Assets	$275.20M
Property, Plant, and Equipment	$24.51M
Long-Term Assets	$431.58M
Total Assets	$706.79M
Current Liabilities	$185.68M
Long-Term Debt	$297.88M
Long-Term Liabilities	$319.81M
Total Liabilities	$505.49M
Common Equity	$201.30M
Tangible Shareholders Equity	$-193.12M
Shareholders Equity	$201.30M
Common Shares Outstanding	82.67M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$6.61M
Cash Flow from Investing Activities	$-2.19M
Cash Flow from Financial Activities	$-13.72M
Beginning Cash	$41.58M
End Cash	$32.91M
Increase/Decrease in Cash	$-8.67M
Stock-Based Compensation	$6.06M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.48
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.60
Debt to Equity Ratio	1.70
Gross Margin	69.14%
Operating Margin	12.44%
EBIT Margin	12.44%
EBITDA Margin	--
Pre-Tax Profit Margin	6.98%
Profit Margin	5.05%
Free Cash Flow	$5.10M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.21
Inventory Turnover	0.47
Receiveable Turnover	1.12
Days Sales in Receivables	80.68
Return on Equity	4.61%
Return on Tangible Equity	-4.80%
Return on Assets	1.31%
Return on Investments	1.86%
Book Value Per Share	$2.43
Free Cash Flow per Share	$0.07
Operating Cash Flow per Share	$0.10

Data from Zacks Investment Research, Inc.